The Latest Breaking News from diabetes

Report highlights 1 million undiagnosed Type 2 diabetes cases in England, stressing early detection and management to prevent complications.

Millions more are at risk of developing the condition

After her mother shared her negative experience with Ozempic, Kelly Osbourne praised the drug as "amazing" during a new interview. The post “They Can’t Afford It”: Kelly Osbourne Slammed For “Classist” Ozempic Comment first appeared on Bored Panda.

The lack of medicine, food and water means thousands of people with asthma, kidney disease or diabetes are unable to treat or control their conditions

Despite concerns over its ability to meet surging semaglutide demand, this Danish pharmaceutical giant holds a dominant position in the diabetes and insulin markets - and now commands the lead in Europe's stock market, too. Here's why NVO is a must-own stock.

Researchers believe that if patients who are likely to respond well to antiseptic mouthwash could be identified, it would be an easy-to-use treatment for people with periodontic-linked diseases.

Two of the most frequent pregnancy-problems">pregnancy problems are hypertensive disorders of pregnancy (HDP) and gestational diabetes (GDM), which increase pregnant people's risk of developing cardiovascular disease later in life. Read further on Dynamite News:

The FDA issues warnings to online vendors selling misbranded weight-loss and diabetes drugs, highlighting potential health risks and illegal practices.

Loss of muscle mass also flagged, as UK drugmaker works with China’s Eccogene on obesity and type 2 diabetes pill

The prevalence of diabetes increased from 10.3% of people in 2001 to 11.6% in 2021.

Eli Lilly (LLY) saw steady growth in its last reported quarter, driven by sales from its popular diabetes drug Mounjaro. The stock has had an impressive run over the past year. However, will the momentum be sustained following its upcoming earnings release scheduled for tomorrow? Read on.